Annual Cash & Cash Equivalents
$70.17 M
+$39.01 M+125.20%
December 31, 2023
Summary
- As of February 7, 2025, RAPP annual cash & cash equivalents is $70.17 million, with the most recent change of +$39.01 million (+125.20%) on December 31, 2023.
- During the last 3 years, RAPP annual cash & cash equivalents has risen by +$39.01 million (+125.20%).
- RAPP annual cash & cash equivalents is now at all-time high.
Performance
RAPP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$39.31 M
-$70.85 M-64.31%
September 30, 2024
Summary
- As of February 7, 2025, RAPP quarterly cash and cash equivalents is $39.31 million, with the most recent change of -$70.85 million (-64.31%) on September 30, 2024.
- Over the past year, RAPP quarterly cash and cash equivalents has dropped by -$34.95 million (-47.06%).
- RAPP quarterly cash and cash equivalents is now -64.31% below its all-time high of $110.16 million, reached on June 30, 2024.
Performance
RAPP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
RAPP Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +125.2% | -47.1% |
| 3 y3 years | +125.2% | - |
| 5 y5 years | +125.2% | - |
RAPP Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +125.2% | -64.3% | at low |
| 5 y | 5-year | at high | +125.2% | -64.3% | at low |
| alltime | all time | at high | +125.2% | -64.3% | at low |
Rapport Therapeutics Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $39.31 M(-64.3%) |
| Jun 2024 | - | $110.16 M(+48.3%) |
| Mar 2024 | - | $74.27 M |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2023 | $70.17 M(+125.2%) | - |
| Dec 2023 | - | $70.17 M |
| Dec 2022 | $31.16 M | - |
FAQ
- What is Rapport Therapeutics annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Rapport Therapeutics?
- What is Rapport Therapeutics annual cash & cash equivalents year-on-year change?
- What is Rapport Therapeutics quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Rapport Therapeutics?
- What is Rapport Therapeutics quarterly cash and cash equivalents year-on-year change?
What is Rapport Therapeutics annual cash & cash equivalents?
The current annual cash & cash equivalents of RAPP is $70.17 M
What is the all time high annual cash & cash equivalents for Rapport Therapeutics?
Rapport Therapeutics all-time high annual cash & cash equivalents is $70.17 M
What is Rapport Therapeutics annual cash & cash equivalents year-on-year change?
Over the past year, RAPP annual cash & cash equivalents has changed by +$39.01 M (+125.20%)
What is Rapport Therapeutics quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of RAPP is $39.31 M
What is the all time high quarterly cash and cash equivalents for Rapport Therapeutics?
Rapport Therapeutics all-time high quarterly cash and cash equivalents is $110.16 M
What is Rapport Therapeutics quarterly cash and cash equivalents year-on-year change?
Over the past year, RAPP quarterly cash and cash equivalents has changed by -$34.95 M (-47.06%)